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Abstract
Background: In neonatal encephalopathy (NE), infectious co-morbidity is difficult to diagnose accurately, but may increase
the vulnerability of the developing brain to hypoxia-ischemia. We developed a novel panel of species-specific real-time PCR
assays to identify bloodstream pathogens amongst newborns with and without NE in Uganda.
Methodology: Multiplex real-time PCR assays for important neonatal bloodstream pathogens (gram positive and gram
negative bacteria, cytomegalovirus (CMV), herpes simplex virus(HSV) and P. falciparum) were performed on whole blood
taken from 202 encephalopathic and 101 control infants. Automated blood culture (BACTEC) was performed for all cases
and unwell controls.
Principal Findings: Prevalence of pathogenic bacterial species amongst infants with NE was 3.6%, 6.9% and 8.9%, with
culture, PCR and both tests in combination, respectively. More encephalopathic infants than controls had pathogenic
bacterial species detected (8.9%vs2.0%, p = 0.028) using culture and PCR in combination. PCR detected bacteremia in 11
culture negative encephalopathic infants (3 Group B Streptococcus, 1 Group A Streptococcus, 1 Staphylococcus aureus and 6
Enterobacteriacae). Coagulase negative staphylococcus, frequently detected by PCR amongst case and control infants, was
considered a contaminant. Prevalence of CMV, HSV and malaria amongst cases was low (1.5%, 0.5% and 0.5%, respectively).
Conclusion/Significance: This real-time PCR panel detected more bacteremia than culture alone and provides a novel tool
for detection of neonatal bloodstream pathogens that may be applied across a range of clinical situations and settings.
Significantly more encephalopathic infants than controls had pathogenic bacterial species detected suggesting that
infection may be an important risk factor for NE in this setting.
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Introduction
Identification of bloodstream infections in newborns, either
alone or as a co-morbidity amongst infants affected by conditions
such as neonatal encephalopathy (NE), is problematic. Clinical
signs associated with neonatal sepsis syndrome, such as lethargy,
poor feeding and convulsions, overlap substantially with other
conditions such as NE. In preclinical studies exposure to bacterial
endotoxin has been shown to increase vulnerability of the
developing brain to perinatal hypoxia-ischemia [1–3]. However,
clinical studies have yet to precisely define the relationship
between perinatal infections and neonatal encephalopathy (NE).
Fetal exposure to inflammation and, or, infection has also been
found to increase brain vulnerability to hypoxia-ischemia via
stimulation of toll-like receptors, immune and inflammatory
responses, chemotaxis and cell death[4–6]. If implicated, the high
prevalence of perinatal infections in the African setting means the
contribution to the etiology of NE may be substantial.
The use of pediatric blood culture techniques in the neonatal
period is complicated by low circulating bacterial load, the small
volumes of blood taken, and because intrapartum antibiotics may
render bacteria non-viable. Open techniques for taking neonatal
blood samples increase the risk of contamination with commensal
organisms making interpretation of results problematic. In
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contrast, real-time PCR techniques need less blood (,500 ul) and
can detect the presence of non-viable bacteria. Additionally, real-
time PCR assays are semi-quantitative, facilitating differentiation
of clinically significant results from contamination.
Despite being a potentially useful adjunct to culture, real-time
PCR for the diagnosis of typical sepsis pathogens from blood in
any group is not frequently reported in the literature. The majority
of studies using molecular techniques to diagnose bloodstream
infections in neonates have focused on broad-range bacterial PCR
assays, mainly those targeting 16 S rDNA [7]. However, despite
the ability of such assays to detect a wide range of bacterial species
their sensitivity is limited by ubiquitous contamination of PCR
reagents with bacterial DNA [8,9]. Well-designed and optimized
species-specific real-time PCR assays offer 100-fold greater
sensitivity [10].
Our aim was to develop a novel panel of species-specific real-
time PCR assays to identify bloodstream pathogens in term infants
with NE in Uganda and to compare the prevalence of pathogenic
bacterial species between encephalopathic infants and unaffected
controls.
Methods
Ethics Statement
London School of Hygiene & Tropical Medicine, Uganda Virus
Research Institute (UVRI) and the Uganda National Council on
Science and Technology ethics committees approved the study.
Informed written parental consent was taken for all study
participants.
Infants were recruited to a larger epidemiological study
examining perinatal risk factors for NE in Uganda (the ‘ABAaNA
study’) September 2011 through October 2012. Infants were
recruited at Mulago Hospital, Kampala, Uganda’s National
Referral Hospital. Participants were in-born term infants, ,12
hours of age. Cases were infants with NE defined according to the
Thompson clinical scoring system [11] with case infants scoring
$6 and controls #3. Concurrently recruited unmatched controls
were randomly selected from labor ward admissions. Exclusion
criteria included living .20 km radius of Mulago Hospital,
neonatal intravenous antibiotics administered prior to recruitment
and parental consent declined.
Aseptic non-touch venepuncture was performed by trained
clinical study staff: 0.5 ml blood (EDTA microfuge tube) for
Figure 1. Flow diagram of study case and control participant.
doi:10.1371/journal.pone.0097259.g001
Table 2. Baseline demographic and clinical characteristics of mothers and babies.
Characteristic Case Control P-valuea
N(%) N(%)
Maternal
Maternal education#primary level 79/202 (39.1) 45/100 (45.0) 0.327
Nulliparity 118/202 (58.4) 49/101 (48.5) 0.102
Emergency caesarean section 49/201(24.4) 23/101(22.8) 0.757
Intrapartum antibiotics 37/201 (18.4) 16/101 (15.8) 0.580
Neonatal
Male sex 132/202 (65.4) 48/101 (47.5) 0.003
Mean birth weight (g) 3183 3033 0.0061
1 minute APGAR ,3 65/195 (33.3) 1/99 (1) ,0.0001
5 minute APGAR ,7 126/177 (71.2) 1/98 (1) ,0.0001
Case fatality 68/200(34.0) 0/96 (0.0) ,0.0001
achi-squared test.
doi:10.1371/journal.pone.0097259.t002
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Table 3. Comparison of species specific bacterial qPCR and BACTEC blood culture for detection of pathogenic bacteria in blood
samples amongst neonatal encephalopathy case infants.
Blood Culture
Positive Negative
PCR Positive 3 11 14
PCR Negative 4 184 188
7 195 202
doi:10.1371/journal.pone.0097259.t003
Table 4. Results of blood culture, real-time PCR assays and sequencing of positives.
Patient Blood culture PCR Sequence
Intrapartum
antibiotics CRP CRP
Day 1 Day 3
GROUP B STREPTOCOCCUS
Case 61 Coagulase Negative
Staphylococcus
Group B Streptococcus – Yes 16.86 50.4
Case 81 Negative Group B Streptococcus – No 47.52 Died D1
Case 170 Negative Group B Streptococcus – No 4.23 Died D1
OTHER STREPTOCOCCUS
Case 133 Negative Group A Streptococcus – No 61.16 Died D1
Case 150 Group C Streptococcus Negative – No 0.28 1.02
STAPHYLOCOCCUS AUREUS
Case 37 S. aureus Negative – No 6.22 4.03
Case 83 Negative S. aureus – No 2.28 30.4
Case 157 S. aureus Negative – Yes 81.55 63.06
Case 166 S. aureus Negative – No 8.18 20.41
Control 5 Not performed S. aureus – No 55.56 n/a
GRAM NEGATIVE ORGANISMS
Case 41 Negative Enterobacteriaceae Enterobacter sp. No 7.58 insuff
Case 53 E.Coli Enterobacteriaceae E.coli or Klebsiella sp. No 1.1 Died D1
Case 56 Negative Enterobacteriaceae Failed No 0.47 Died D1
Case 64 Negative Enterobacteriaceae Failed No 0.22 13.16
Case 67 Negative Enterobacteriaceae Enterobacter sp. No 0.14 Died D1
Case 82 Negative Enterobacteriaceae Pantoea sp. No 8.91 Died D1
Case 117 Negative Enterobacteriaceae E.Coli Yes 32.81 Died D1
MULTIPLE ORGANISMS
Case 132 S. aureus S. aureus – No 49.01 –
Enterobacteriaceae E.Coli
Cytomegalovirus –
Case 49 Klebsiella sp. Enterobacteriaceae Klebsiella sp. Yes 3.61 9.32
P. falciparum –
Control 65 Not performed Enterobacteriaceae E.Coli No 1.83 n/a
S. pneumoniae –
VIRUSES & MALARIA
Case 10 Negative Cytomegalovirus – n/a 2.68 Died D1
Case 16 Negative Cytomegalovirus – n/a 0.16 Died D1
Control 21 Not perform Cytomegalovirus – n/a 0.32 n/a
Case 175 Negative Herpes Simplex Virus 1 – n/a 0.35 2.79
Control 98 Not performed P. falciparum – n/a 1.38 n/a
doi:10.1371/journal.pone.0097259.t004
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quantitative PCR (all infants), 0.5–1.0 ml whole blood inoculated
into a single pediatric blood culture (BC) bottle (BACTEC Peds
Plus, Becton Dickinson, Sparks MD; all cases and control infants
clinically unwell on assessment), and 0.5 ml (serum microfuge
tube) for C-reactive protein (CRP) (all infants, COBAS, Roche
Diagnostics). A repeat sample for CRP was taken after 48 hours
amongst surviving cases. Culture bottles were loaded into the
Bactec 9240 automated instrument at the MRC/UVRI microbi-
ology laboratory. Gram-stained, subcultured, and purified colonies
were manually identified from positive cultures.
Bead-beating of EDTA-blood samples (300 ml) was performed
to ensure complete lysis of bacterial cells. DNA (200 ml elute) was
extracted using the QiAmp DNA blood mini kit and a QIAcube
semi-automated extraction platform (both Qiagen, Manchester,
UK). Each batch (12 samples) included a negative extraction
control (200 ml of buffer AE, Qiagen). CT and PN performed all
DNA extraction in the MRC/UVRI virology laboratories.
Ten targets and an internal control were amplified in five
separate multiplexed reactions (Table 1) on a 7500 Fast Real Time
PCR system (Life Technologies, Paisley, UK). Cycling conditions
were 95uC for 5 minutes then 45 cycles of 95uC for 30 seconds and
60uC for 30 seconds. A positive result was any target detected with
a cycle-threshold (CT) value ,38. A no template control was
included for each multiplexed assay. A positive control was
included for every target organism. For bacterial targets this was
DNA extracted from suspensions of cultured laboratory strains of
known provenance, for viral targets this was plasmid DNA and for
Plasmodium falciparum this was a microscopically positive clinical
sample. A valid run required detection of each positive control
with a CT value within a set range (normally 28.5–31.5). For
bacterial assays suspensions of control organisms were quantified
using a plate-counting method and for viral assays plasmid DNA
was quantified using the NanoDrop Spectrophotometer (Labtech,
Uckfield, UK). PCR assays were performed in the laboratories of
UVRI and Great Ormond Street Hospital (GOSH), by CT and
KH. Clinical staff and technicians were not blinded to case control
status. Blood culture results were not available to staff prior to
performing PCR assays.
Enterobacteriaceae PCR positives were further identified by
amplicon sequencing using Big-Dye 3.1 Cycle-sequencing kit (Life
Technologies) and analyzed on a 3130 Genetic Analyse (Life
Technologies). Sequences were compared to an in-house database
of Enterobacteriaceae dnaK sequences using MegAlign (Lasergene
10, DNAStar, Madison, WI, USA) or by BLAST searching against
the Genbank database (http://www.ncbi.nlm.nih.gov).
The prevalence of bacteremia between cases and controls was
compared using the Chi-squared test using STATA version 12.0.
Results
Samples from 202 case and 101 controls were examined
(Figure 1). Most encephalopathic infants were moderately or
severely affected (89.1%, n= 180). Compared to controls they
were more likely to be male, have abnormal APGAR scores at one
and five minutes, and have a higher mean birth weight (Table 2).
Intrapartum antibiotic use was similar.
Comparison of Bacterial PCR and Culture Results
amongst Infants with NE vs. Controls
The prevalence of neonatal bacteremia with a pathogenic
organism amongst encephalopathic infants was 3.5% (7) by BC
alone, 6.9% (14) by PCR alone and 8.9% (18) by BC and PCR in
combination (Table 3). Of the 101 control infants, none was
positive for pathogenic bacterial species on BC but two were
positive on PCR, giving a prevalence of neonatal bacteremia
amongst the control group of 2.0% (2/101). Four control infants
were clinically unwell on recruitment, so BCs were performed in
addition to PCR; all 4 were negative on both tests. The prevalence
of bacteremia (by either BC or PCR) was significantly higher
amongst infants with encephalopathy than those without (8.9% vs.
2.0% respectively, p-value = 0.028). Coagulase negative staphylo-
coccus (CoNS), usually considered non-pathogenic amongst term
newborns, was more commonly found on PCR amongst controls
compared to cases, but this difference was not statistically
significant (9.9% (9/101) in controls vs. 5.5% (11/202) in cases,
p = 0.252).
Case Infants with Positive Blood-cultures
Seven case infants had a positive BC, four of these (3
Staphylococcus aureus and 1 Group C Streptococcus) were PCR
negative. The other three cases also yielded a positive PCR result;
one E. coli by both methods, a second S. aureus by both methods
but also PCR positive for the Enterobacteriaceae target and a
third case was BC positive for CoNS but PCR positive for Group
B Streptococcus (GBS) (Table 4).
Cases with Negative Blood-cultures
One hundred and ninety five case infants had negative BCs, 184
of these were also negative by PCR.
The remaining 11 BC negative cases were positive by real-time
PCR for a bacterial target (3 GBS, 1 Group A Streptococcus
(GAS), 1 S. aureus and 6 Enterobacteriaceae). Of the five infants
PCR positive, BC negative for pathogenic streptococcal or
staphylococcal species, four had substantially raised CRP levels
on day 1 or day 3 and the fifth (case 170) died ,24 hours after a
clinical course consistent with aggressive GBS septicemia with
persistent hyperthermia, severe respiratory distress and seizures.
Sequencing of the Enterobacteriaceae amplicon in the 6 positive
cases allowed identification of a pathogenic organism (at least to
genus level) in 4 cases (2 Enterobacter sp., 1 Pantoea sp. and 1 E. coli)
but was unsuccessful in 2 cases therefore these are identified only
as Enterobacteriaceae (Table 4).
In the absence of normative CRP data for this population, a
raised CRP was defined as CRP.97thcentile amongst controls
( = 40.7 mg/L). Of case infants without evidence of bacteremia on
PCR or BC, 5.0% (9/181) had a raised CRP on day one, rising to
16.2% (19/117) on day 3 amongst survivors. Bacteraemic case
infants were significantly more likely to have a raised CRP on day
one compared to non-bacteraemic infants (22.2% (4/18) vs. 5.0%
(9/181), p = 0.005).
Cytomegalovirus, Herpes Simplex & Malaria
The prevalence of cytomegalovirus (CMV) infection was 1.5%
(3/202) amongst cases and 1.0% (1/101) in controls. Herpes
simplex virus (HSV) was identified in one case infant (0.5%) and
P. falciparum in one case and one control infant.
Discussion
The accurate diagnosis of infectious co-morbidity in the unwell
newborn through clinical signs or standard culture techniques is
problematic [12]. Our novel panel of multiplexed real-time PCR
assays, designed to cover the majority of common pathogens
implicated in congenital neonatal infections, was successful in
detecting more bacteremia than culture alone amongst encepha-
lopathic Ugandan newborns. A significantly higher prevalence of
potentially pathogenic bacterial species was seen in encephalo-
pathic babies when compared to controls suggesting that fetal
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exposure to bacterial blood-borne pathogens may be a causal
factor for neonatal encephalopathy in this setting. This may be
mediated by cytokines and inflammatory cells which have been
found to be intermediaries in perinatal brain injury secondary to
hypoxia-ischemia, neurotoxins and infection [13] or by enhanced
sensitivity of the brain to hypoxia-ischemia after exposure to
bacterial products such as endotoxin3.
Eleven culture-negative encephalopathic infants tested positive
on bacterial PCR for pathogenic organisms. Amongst these, two
organisms could only be identified and as Enterobacteriaceae and
as this family contains environmental non-pathogenic species,
interpretation of these two PCR positives is uncertain. Coagulase
negative staphylococcus, considered non-pathogenic in the
absence of indwelling catheters, was common amongst both case
and control infants. Open venepuncture may have contributed to
an increased contamination risk. False positive PCR results due to
laboratory contamination are unlikely since negative controls were
consistently negative and strict laboratory practice was followed to
prevent contamination.
The prevalence of congenital cytomegalovirus (CMV) is thought
to be high in low income settings (1–5%) where it is commonly
secondary to non-primary maternal infections [14]. No Ugandan
studies have published rates of congenital CMV infection. Our
prevalence of 1% amongst controls is substantially lower than that
reported from a recent birth cohort in the Gambia (5.4%) [15].
Our prevalence of congenital CMV was similar between
encephalopathic and non-encephalopathic infants suggesting that
CMV does not contribute to the burden of neonatal encephalop-
athy in this setting. Herpes Simplex and P. falciparum infections
were similarly uncommon.
There are limitations of all laboratory techniques utilized in the
detection of bacteremia. In our study, important pathogens such as
GBS, S. aureus and Enterobacteriaceae were detected by PCR but
not culture; however bacteremia in four infants was detected by
culture alone. This was most common for S. aureus, a robust
organism that grows well in the laboratory hence culture may be
more sensitive than PCR for detecting low levels of S. aureus
bacteremia in these infants. Even a combination of PCR and
culture is unlikely to exclude all infants with early sepsis,
highlighted by the substantial number of culture negative/PCR
negative infants with a substantially raised CRP on either day one
or day 3. This emphasizes the importance of empirical antibiotic
therapy to all sick newborns including those with NE. In addition,
PCR assays offer no information on antimicrobial susceptibility,
and contamination with commensal and environmental organisms
remains an issue for all techniques.
In conclusion, we have found high levels of bacteremia in
infants with NE in an African setting using a combination of blood
culture and species-specific real-time PCR assays to identify
bloodstream pathogens. Significantly more encephalopathic in-
fants than controls had pathogenic bacterial species detected
suggesting that neonatal bacteremia may be an important risk
factor for NE in this setting. Our real-time PCR panel detected
more bacteremia than culture alone and provides a novel tool for
detection of neonatal bloodstream pathogens that could be applied
across a range of clinical situations and settings.
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